Sale

Hormone Replacement Therapy Market

Global Hormone Replacement Therapy Market Size, Growth: By Product: Estrogen & Progesterone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Others; By Route of Administration; By Type of Disease; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Hormone Replacement Therapy Market Outlook

The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023 and is projected to reach USD 10.00 billion by 2032, growing at a CAGR of 6.9% over the forecast period of 2024-2032.

 

Global Hormone Replacement Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the product type, the oestrogen replacement therapy segment held the majority of the market share in 2020. Based on the route of administration, the parenteral segment is estimated to be the leading segment, accounting for the majority of the market share, followed by oral and transdermal methods.

Regionally, the market is segmented into North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America was the largest market in 2020, accounting for the majority of the market share.

 

Properties and Applications 

Hormone replacement therapy (HRT) is a treatment used for replenishing the hormones which are present in low levels in the human body. This therapy is particularly favourable for the patients having a deficiency of growth hormone, women in menopausal transition, and geriatric suffering from hypogonadism. It is available in several forms, such as gels, skin, and mouth patches (transdermal), injections, and implants. It is also considered to be a more efficient treatment in comparison to its alternatives, such as chemical drugs, herbal medicines, and others.

 

Hormone Replacement Therapy Market By Type Of Disease

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major product types of the market are:

  • Oestrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

On the basis of route of administration, the industry can be segmented into:

  • Oral
  • Parenteral
  • Transdermal

Based on the type of diseases, the market is divided into:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

The EMR report looks into the regional markets like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.

 

Hormone Replacement Therapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis 

A rise in the incidences of hormonal imbalance disorders in the neonatal and geriatric populations is primarily driving the market growth. HRT is effective for the treatment of the symptoms of menopause such as night sweats, hot flashes, vaginal dryness, and sexual function. Additionally, it minimises the risk of cardiovascular diseases, vasomotor symptoms, colorectal cancer, and osteoporosis while improving the quality of life. Furthermore, advancements in technology such as the introduction of transdermal drug delivery and new gel-based formulations, coupled with increased investments in research and development activities by the manufacturers are providing a boost to the market growth. Moreover, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations are further expected to stimulate the demand for hormone replacement therapy during the forecast period.

 

Competitive Landscape 

The report presents a detailed analysis of the following key players in the global hormone replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Novo Nordisk A/S
  • Abbott Laboratories Inc.
  • Pfizer Inc
  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Viatris Inc.
  • Eli Lilly and Company
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • AbbVie Inc.

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Route of Administration
  • Type of Disease
  • End User
  • Distribution Channel
  • Region
Breakup by Product
  • Estrogen & Progesterone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Transdermal
  • Other
Breakup by Type of Disease
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
Breakup by End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Novo Nordisk A/S
  • Abbott Laboratories Inc.
  • Pfizer Inc
  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Viatris Inc.
  • Eli Lilly and Company
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • AbbVie Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Hormone Replacement Therapy Overview 

    3.1    Global Hormone Replacement Therapy Market Historical Value (2017-2023) 
    3.2    Global Hormone Replacement Therapy Market Forecast Value (2024-2032)
4    Global Hormone Replacement Therapy Market Landscape
    4.1    Global Hormone Replacement Therapy Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Hormone Replacement Therapy Product Landscape
        4.2.1    Analysis by Patent Type
        4.2.2    Analysis by End user
        4.2.3    Analysis by Distribution Channel
5    Global Hormone Replacement Therapy Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Hormone Replacement Therapy Market Segmentation
    6.1    Global Hormone Replacement Therapy Market by Product
        6.1.1    Market Overview 
        6.1.2    Estrogen & Progesterone Replacement Therapy  
        6.1.3    Human Growth Hormone Replacement Therapy 
        6.1.4    Thyroid Replacement Therapy 
        6.1.5    Testosterone Replacement Therapy 
        6.1.6    Others
    6.2    Global Hormone Replacement Therapy Market by Route of Administration
        6.2.1    Market Overview
        6.2.2    Oral
        6.2.3    Parenteral
        6.2.4    Transdermal
        6.2.5    Other
    6.3    Global Hormone Replacement Therapy Market by Type of Disease
        6.3.1    Market Overview
        6.3.2    Menopause
        6.3.3    Hypothyroidism
        6.3.4    Male Hypogonadism
        6.3.5    Growth Hormone Deficiency
        6.3.6    Others
    6.4    Global Hormone Replacement Therapy Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Homecare
        6.4.4    Specialty Clinics
        6.4.5    Others
    6.5    Global Hormone Replacement Therapy Market by Distribution Channel
        6.5.1    Market Overview
        6.5.2    Hospital Pharmacy
        6.5.3    Retail Pharmacy
        6.5.4    Online Pharmacy
    6.6    Global Hormone Replacement Therapy Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Hormone Replacement Therapy Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Hormone Replacement Therapy Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Hormone Replacement Therapy Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Hormone Replacement Therapy Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Hormone Replacement Therapy Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1     Novo Nordisk A/S
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Abbott Laboratories Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Pfizer Inc
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Allergan
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Bayer AG
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Merck & Co., Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Viatris Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Eli Lilly and Company
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Koninklijke Philips N.V.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    F. Hoffmann-La Roche Ltd. (Genentech)
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    ASCEND Therapeutics US, LLC. (Besins Healthcare)
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    AbbVie Inc.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
18    Global Hormone Replacement Therapy Market- Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global hormone replacement therapy market attained a value of nearly USD 5.50 billion.

The market is projected to grow at a CAGR of 6.9% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 10.00 billion by 2032.

The major drivers of the industry, such as rise in the incidences of hormonal imbalance disorders, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations, are expected to aid the market growth.

The key market trend guiding the growth of the hormone replacement therapy market includes the introduction of transdermal drug delivery and new gel-based formulations.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share. 

The oestrogen replacement therapy segment is the leading product in the industry.

The route of administration is led by parenteral segment in the industry. 

The significant types of diseases in the industry are menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency, among others.

The major players in the industry are Abbott, Novo Nordisk A/S, Pfizer Inc, and Allergan, among others.

Analyst Review

The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023, driven by the increasing awareness among the consumers. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.9%. The market is projected to reach USD 10.00 billion by 2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product type, the oestrogen replacement therapy segment is the dominant product in the industry. On the basis of route of administration, the parenteral segment is the leading segment. On the basis of type of disease, the industry is divided into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and others. The major regional markets for hormone replacement therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the industry. The key players in the above industry include Abbott, Novo Nordisk A/S, Pfizer Inc, Allergan, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER